Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low‐grade glioma

In pediatric low‐grade gliomas not amenable to complete resection, various chemotherapy regimens are the mainstream of treatment. An excellent overall survival of these patients makes justification of the intensification of chemotherapy difficult and calls for the development of new strategies. Beva...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhukova, Nataliya, Rajagopal, Revathi, Lam, Adrienne, Coleman, Lee, Shipman, Peter, Walwyn, Thomas, Williams, Molly, Sullivan, Michael, Campbell, Martin, Bhatia, Kanika, Gottardo, Nicholas G., Hansford, Jordan R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346232/
https://www.ncbi.nlm.nih.gov/pubmed/30569607
http://dx.doi.org/10.1002/cam4.1799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346232/
https://www.ncbi.nlm.nih.gov/pubmed/30569607
http://dx.doi.org/10.1002/cam4.1799

Ejemplares similares